Literature DB >> 15301298

Evaluation of the nocebo effect during oral challenge in patients with adverse drug reactions.

G Liccardi1, G Senna, M Russo, P Bonadonna, M Crivellaro, A Dama, M D'Amato, G D'Amato, G W Canonica, G Passalacqua.   

Abstract

The nocebo effect is the onset of untoward reactions following the administration of an indifferent substance. The oral challenge with alternative drugs plays a central role in the management of drug allergy and the use of inert substances is part of this procedure. We evaluated the occurrence and clinical characteristics of nocebo effect in patients with adverse drug reactions. Six hundred patients, seen in three different centres (Genoa, Naples and Verona) with a history of reactions to drugs, underwent a blind oral challenge with the administration of an indifferent substance and active drugs. The administration of an inert substance provoked untoward reactions in 54 patients (27%) in Verona, 60 (30%) in Naples and 48 (24%) in Genoa. The overall occurrence of nocebo effect was 27%. The majority of reactions were subjective symptoms (itching, malaise, headache etc), perceived as troublesome by all subjects. The occurrence was significantly higher in women than in men. Our data, collected in a large population, confirm that the nocebo effect occurs frequently in clinical practice. In managing adverse drug reactions through oral challenge the nocebo effect is mandatory to recognize false positive responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15301298

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN: 1018-9068            Impact factor:   4.333


  26 in total

Review 1.  Adverse events associated with single dose oral analgesics for acute postoperative pain in adults - an overview of Cochrane reviews.

Authors:  R Andrew Moore; Sheena Derry; Dominic Aldington; Philip J Wiffen
Journal:  Cochrane Database Syst Rev       Date:  2015-10-13

Review 2.  Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis.

Authors:  Winfried Rief; Yvonne Nestoriuc; Anna von Lilienfeld-Toal; Imis Dogan; Franziska Schreiber; Stefan G Hofmann; Arthur J Barsky; Jerry Avorn
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

3.  A meta-analytic approach to estimating nocebo effects in neuropathic pain trials.

Authors:  Dimitrios Papadopoulos; Dimos Dimitrios Mitsikostas
Journal:  J Neurol       Date:  2011-08-03       Impact factor: 4.849

Review 4.  [Placebo and nocebo effects on itch : Methodological and clinical implications].

Authors:  J Tekampe; K J Peerdeman; D J P Bartels; A I M van Laarhoven; A W M Evers
Journal:  Hautarzt       Date:  2018-08       Impact factor: 0.751

Review 5.  Characterization of the adverse events profile of placebo-treated patients in randomized controlled trials on drug-resistant focal epilepsies.

Authors:  Fabio Giovannelli; Gaetano Zaccara; Massimo Cincotta; Giulia Loiacono; Alberto Verrotti
Journal:  J Neurol       Date:  2014-10-14       Impact factor: 4.849

Review 6.  Lessons learned from placebo groups in antidepressant trials.

Authors:  Meike Shedden Mora; Yvonne Nestoriuc; Winfried Rief
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-06-27       Impact factor: 6.237

7.  Multiple drug intolerance syndrome and multiple drug allergy syndrome: Epidemiology and associations with anxiety and depression.

Authors:  K G Blumenthal; Y Li; W W Acker; Y Chang; A Banerji; S Ghaznavi; C A Camargo; L Zhou
Journal:  Allergy       Date:  2018-10       Impact factor: 13.146

Review 8.  The nocebo effect and its relevance for clinical practice.

Authors:  Luana Colloca; Franklin G Miller
Journal:  Psychosom Med       Date:  2011-08-23       Impact factor: 4.312

9.  Qualitative study of Nocebo Phenomenon (NP) involved in doctor-patient communication.

Authors:  Bushra Ashraf; Muhammad Saaiq; Khaleeq-Uz- Zaman
Journal:  Int J Health Policy Manag       Date:  2014-06-02

10.  Diagnostic evaluation of food-related allergic diseases.

Authors:  John Eckman; Sarbjit S Saini; Robert G Hamilton
Journal:  Allergy Asthma Clin Immunol       Date:  2009-10-22       Impact factor: 3.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.